Immediate Suture or Directed Wound Healing? Comparative Study of Their Respective Values Following a Punch Skin Biopsy (CICAT)

Sponsor
Centre Hospitalier le Mans (Other)
Overall Status
Recruiting
CT.gov ID
NCT04623372
Collaborator
(none)
400
1
2
20.9
19.1

Study Details

Study Description

Brief Summary

The skin punch-biopsies are frequently used technical acts in the current medical practice. However, while these skills are actually easy to perform, the subsequent healing procedure remains still poorly harmonized. Indeed, it usually depends on the physicians personal experiences and some preconceived considerations without any reliable scientific background. This study aims to explore the performances of a directed wound healing behaviour in comparison with the suture.

Condition or Disease Intervention/Treatment Phase
  • Procedure: suture
  • Procedure: directed wound healing
N/A

Detailed Description

Because of the lack of reliable scientific data about this topic, the usual behaviours concerning the subsequent healing procedure after a punch skin biopsy remains still poorly defined and harmonized, currently based on the physicians personal experiences and some preconceived considerations. The few studies available in the literature are supporting the assumption that the use of a directed wound healing could be as effective as the widely-used procedure of performing a suture while it does not downgrade the quality of care. However, due to their methodological quality and applicability, they have not led to a substantial modification of the common behaviours. Moreover, the development of some new and the improvement of the former resources could have changed the situation. Therefore, this study aims to bring some recent pragmatic data to assist the implementation of recommendations regarding the attitude to adopt for the healing procedure after a skin punch-biopsy.

The protocol will consist in a monocentric, prospective, randomized and controlled, interventional study. It will be carried out with two parallel groups, in a non-inferiority setting. All the included participants will undergo a skin biopsy using a punch of 4 mm diameter. Then they will either get a suture by separated knots using a non-absorbable 4.0 wire and a dry dressing, either get only a dry dressing. All the subjects will receive a phone call at five days after the skin biopsy in order to collect the self-evaluation of the maximal experienced pain during the healing period. They will also have a single follow-up appointment one month after the inclusion and a photograph of the scar will be taken during this medical consultation. This picture will be evaluated by a blind independent investigator without the presence of the patient.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
two parallel groups, in a non-inferiority setting, without any pairing or stratificationtwo parallel groups, in a non-inferiority setting, without any pairing or stratification
Masking:
Single (Outcomes Assessor)
Masking Description:
One month after the inclusion a photograph of the scar will be taken. This picture will be evaluated by a blind independent investigator without the presence of the patient.
Primary Purpose:
Other
Official Title:
Immediate Suture or Directed Wound Healing? Comparative Study of Their Respective Values Following a Punch Skin Biopsy (CICAT)
Actual Study Start Date :
Feb 3, 2021
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: suture

Procedure: suture
suture by separated knots using a non-absorbable 4.0 wire and application of a dry dressing after the punch skin-biopsy

Experimental: Directed wound healing

Procedure: directed wound healing
application of a dry dressing without any prior suture after the skin biopsy.

Outcome Measures

Primary Outcome Measures

  1. Assess aesthetic quality of the scar by physician [one month after skin punch biopsy]

    the asserted aesthetic quality of the scar will be assessed by a dermatologist with 4-level scale

Secondary Outcome Measures

  1. Assess aesthetic quality of the scar by patient [1 month after skin biopsy punch]

    The asserted aesthetic quality of the scar will be assessed by the participant himself using a 4-level scale

  2. Assess maximal pain experienced by the patient [1 month after skin biopsy punch]

    The maximal pain experienced by the patient during the Healing phase will be assessed with a numerical scale ranging from 0 to 10

  3. Assess amount of bleeding [immediately after skin biopsy punch]

    the scoring of the amount of bleeding subsequent to the skin biopsy will be assessed with a numerical scale ranging from 0 to 10

  4. Assess clotting time [immediately after skin biopsy punch]

    The clotting time subsequent to the skin biopsy will be assessed using a 4-level scale

  5. Observe cutaneous infection [1 month after skin biopsy punch]

    occurrence of a cutaneous infection that had required an antibiotic treatment and/or the achievement of a drainage during the month following the skin punch-biopsy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adult person (age greater than or equal to 18 years)

  • either hospitalized patient in a conventional or in a day care department, either seen at a medical appointment in Le Mans General Hospital

  • person on whom the indication of one or several skin biopsy(ies) using a punch of 4 mm diameter has been established

  • affiliated or beneficiary of a statutory social insurance scheme

  • free and informed written consent, signed by both the participant and the investigator (the day of inclusion at the latest and prior to any examination needed by the protocol) after an oral and written information

Exclusion Criteria:
  • skin biopsy on the face or the cervical area

  • pregnant, breastfeeding or parturient woman

  • person deprived of liberty by an administrative act or a court decision

  • patient requiring compulsory mental health care

  • minor or legally protected adult

  • patient that is no longer in a condition to express his or her wishes

  • person that have participated or that are taking part in an interventional study over the past 30 days (condition of exclusivity)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Du Mans Le Mans France 72000

Sponsors and Collaborators

  • Centre Hospitalier le Mans

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier le Mans
ClinicalTrials.gov Identifier:
NCT04623372
Other Study ID Numbers:
  • CHM-2020/S11/02
First Posted:
Nov 10, 2020
Last Update Posted:
Mar 9, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier le Mans

Study Results

No Results Posted as of Mar 9, 2022